Japan pledges $130M to infectious disease fund

May 24, 2016 News BioVox

The Japanese government will invest an additional $130 million in the The Global Heath Innovative Technology (GHIT) Fund, which supports R&D on infectious diseases including malaria, tuberculosis, HIV and neglected tropical diseases.

The fund is a public-private partnership among seven Japanese pharmaceutical companies, the Japanese government, the Bill & Melinda Gates Foundation, the Wellcome Trust and the United Nations Development Program. The fund said it has invested more than $60 million in 60 development partnerships, and has started seven clinical trials in high-burden countries.

Japan’s Ministry of Health, Labor and Welfare (MHLW) and Ministry of Foreign Affairs each pledged Y700 million ($7.2 million) to help launch the fund in 2013.

Adapted from BioCentury


Avatar photo
BioVox

With a local focus and global reach, BioVox shares insights into the Belgian life sciences ecosystem with an ever-growing global community. BioVox is a non-profit project: we are able to provide our community with free, quality content because of the generous support of Turnstone Communications and its clients. Our articles bring you hidden opportunities and exclusive insights into the latest research and industry trends!

All posts